LYKALABS — Lyka Labs Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapFalling Star

Annual income statement for Lyka Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	C2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	615	863	1,941	931	1,112
Cost of Revenue
Gross Profit	257	483	1,411	555	615
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,064	753	1,168	978	1,087
Operating Profit	-449	110	773	-47	25
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-619	-141	592	-132	-9.34
Provision for Income Taxes
Net Income After Taxes	-626	-101	384	-132	-26.2
Minority Interest
Net Income Before Extraordinary Items
Net Income	-605	-116	390	-132	-24.9
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-605	-116	390	-132	-24.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-13.7	-3.77	15.1	-2.92	-0.667